261 related articles for article (PubMed ID: 24012680)
1. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
[TBL] [Abstract][Full Text] [Related]
2. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
3. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
Allen K; Jaeschke H; Copple BL
Am J Pathol; 2011 Jan; 178(1):175-86. PubMed ID: 21224055
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
5. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
6. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
8. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
[TBL] [Abstract][Full Text] [Related]
9. Activation of necroptosis in human and experimental cholestasis.
Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Luyendyk JP; Kassel KM; Allen K; Guo GL; Li G; Cantor GH; Copple BL
Am J Pathol; 2011 Mar; 178(3):1117-25. PubMed ID: 21356363
[TBL] [Abstract][Full Text] [Related]
11. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice.
Zhang S; Huang D; Weng J; Huang Y; Liu S; Zhang Q; Li N; Wen M; Zhu G; Lin F; Gu W
Scand J Immunol; 2016 Feb; 83(2):102-8. PubMed ID: 26484852
[TBL] [Abstract][Full Text] [Related]
13. Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice.
Sullivan BP; Cui W; Copple BL; Luyendyk JP
Toxicol Sci; 2012 Mar; 126(1):267-74. PubMed ID: 22094456
[TBL] [Abstract][Full Text] [Related]
14. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
[TBL] [Abstract][Full Text] [Related]
15. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Zhang L; Pan Q; Zhang L; Xia H; Liao J; Zhang X; Zhao N; Xie Q; Liao M; Tan Y; Li Q; Zhu J; Li L; Fan S; Li J; Zhang C; Cai SY; Boyer JL; Chai J
Hepatology; 2023 Jun; 77(6):1866-1881. PubMed ID: 36647589
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
[TBL] [Abstract][Full Text] [Related]
17. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
[TBL] [Abstract][Full Text] [Related]
18. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
20. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
